Skip to main content
. Author manuscript; available in PMC: 2015 Jun 14.
Published in final edited form as: Acta Neurochir Suppl. 2015;120:89–94. doi: 10.1007/978-3-319-04981-6_15

Figure 2. MMP-2 activity is enhanced in cerebral arteries from SAH model animals.

Figure 2

a) An example of gelatin zymography demonstrating activity of commercially purified MMP-2 and cerebral artery homogenate from a control animal. B) Gelatin zymography demonstrating enhanced MMP-2 activity in homogenates obtained from SAH model animals. c) Summary data showing significantly greater MMP-2 activity in cerebral artery homogenates from SAH model animals compared to cerebral artery homogenates from un-operated control animals. (n = 8 for each) d) Summary data demonstrating that MMP-2 mRNA levels are similar in cerebral artery homogenates obtained from control and SAH model animals (n = 7 for each). ** P < 0.01 vs control, unpaired students t-test.